An open-label prospective clinical study of the efficacy and tolerability of brand-name and generic levetiracetam in the monotherapy of focal epilepsy in adults

An open-label prospective clinical study of the efficacy and tolerability of brand-name and generic levetiracetam in the monotherapy of focal epilepsy in adults

Objective: to comparatively evaluate the clinical efficacy and tolerability of monotherapy with levetiracetam (LEV), a brand-name drug (bLEV; Keppra, UCB Pharma, Belgium) and its generic (gLEV;  Epiterra, TEVA, Israel) in adolescent (over 16 years of age) and adult patients with focal epilepsy (FE)...

Full description

Bibliographic Details
Main Authors: V. A. Karlov, P. N. Vlasov, I. A. Zhidkova
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2018-07-01
Series:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Subjects:
focal epilepsy
adult patients
adolescents over 16 years of age
levetiracetam
brand-name formulation
generic formulation
efficacy
tolerability
adverse events
quality of life
Online Access:https://nnp.ima-press.net/nnp/article/view/903

Internet

https://nnp.ima-press.net/nnp/article/view/903

Similar Items